NeueHealth (NYSE:NEUE – Get Free Report) is one of 13 public companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its peers? We will compare NeueHealth to similar businesses based on the strength of its earnings, dividends, analyst recommendations, risk, profitability, valuation and institutional ownership.
Analyst Ratings
This is a summary of current recommendations for NeueHealth and its peers, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 87 | 1097 | 2474 | 97 | 2.69 |
NeueHealth currently has a consensus target price of $8.00, indicating a potential upside of 30.93%. As a group, “Hospital & medical service plans” companies have a potential upside of 15.58%. Given NeueHealth’s higher possible upside, research analysts clearly believe NeueHealth is more favorable than its peers.
Earnings and Valuation
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $86.71 billion | $2.99 billion | 11.86 |
NeueHealth’s peers have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
63.9% of NeueHealth shares are held by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by company insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares NeueHealth and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | 0.18% | -0.61% | 0.48% |
Risk and Volatility
NeueHealth has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s peers have a beta of 0.89, suggesting that their average share price is 11% less volatile than the S&P 500.
Summary
NeueHealth peers beat NeueHealth on 10 of the 13 factors compared.
NeueHealth Company Profile
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.